Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2025-12-25 @ 3:45 AM
NCT ID:
NCT02043002
Eligibility Criteria:
Inclusion Criteria:
* Lung Cancer patients with non-small cell histology and stage IV disease
* candidate for erlotinib treatment as first/ second/ third line of treatment
Exclusion Criteria:
* pregnancy
* severe dyspnoea
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02043002
Study Brief:
Protocol Section:
NCT02043002